| Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic … OA O'Connor, ML Heaney, L Schwartz, S Richardson, R Willim, ... Journal of Clinical Oncology 24 (1), 166-173, 2006 | 477 | 2006 |
| Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor CH Wong, L Nguyen, J Peh, LM Luu, JS Sanchez, SL Richardson, ... Journal of the American Chemical Society 136 (17), 6355-6361, 2014 | 112 | 2014 |
| Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors G Zhang, SL Richardson, Y Mao, R Huang Organic & biomolecular chemistry 13 (14), 4149-4154, 2015 | 61 | 2015 |
| Kinetic mechanism of protein N-terminal methyltransferase 1 SL Richardson, Y Mao, G Zhang, P Hanjra, DL Peterson, R Huang Journal of Biological Chemistry 290 (18), 11601-11610, 2015 | 43 | 2015 |
| Investigating the binding mode of an inhibitor of the MBNL1· RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder CH Wong, SL Richardson, YJ Ho, AMH Lucas, T Tuccinardi, AM Baranger, ... Chembiochem: a European journal of chemical biology 13 (17), 2505, 2012 | 26 | 2012 |
| A new strategy for the in vitro selection of stapled peptide inhibitors by mRNA display ES Iqbal, SL Richardson, NA Abrigo, KK Dods, HEO Franco, HS Gerrish, ... Chemical communications 55 (61), 8959-8962, 2019 | 25 | 2019 |
| A direct, ratiometric, and quantitative MALDI–MS assay for protein methyltransferases and acetyltransferases SL Richardson, P Hanjra, G Zhang, BD Mackie, DL Peterson, R Huang Analytical biochemistry 478, 59-64, 2015 | 21 | 2015 |
| Direct, competitive comparison of linear, monocyclic, and bicyclic libraries using mRNA display DE Hacker, NA Abrigo, J Hoinka, SL Richardson, TM Przytycka, ... ACS Combinatorial Science 22 (6), 306-310, 2020 | 20 | 2020 |
| In vitro genetic code reprogramming and expansion to study protein function and discover macrocyclic peptide ligands SL Richardson, KK Dods, NA Abrigo, ES Iqbal, MCT Hartman Current opinion in chemical biology 46, 172-179, 2018 | 14 | 2018 |
| Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SARA). WK Kelly, O O'Connor, VM Richon, T Curley, S Richardson, D Thapi, ... Clinical Cancer Research 9 (16), 6245S-6246S, 2003 | 9 | 2003 |
| Ventriculitis caused by primary T-cell cns lymphoma in an immunocompetent patient M Nigo, S Richardson, E Azizi, JM Cohen, I Shapira Journal of Clinical Oncology 34 (15), e145-e147, 2016 | 5 | 2016 |
| Calcein represses human papillomavirus 16 E1-E2 mediated DNA replication via blocking their binding to the viral origin of replication D Das, NW Smith, X Wang, SL Richardson, MCT Hartman, IM Morgan Virology 508, 180-187, 2017 | 2 | 2017 |
| Calcein represses human papillomavirus 16 E1-E2 mediated DNA replication via blocking their binding to the viral origin of replication. DD Dipon Das, NW Smith, WX Wang Xu, SL Richardson, MCT Hartman, ... | | 2017 |
| Towards the development of a peptide-PROTAC conjugate targeting a viral protein: Rational design and optimization of a stapled alpha-helical peptide that binds HPV16 E2 protein S Richardson, M Hartman ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 254, 2017 | | 2017 |
| Identification and investigation of RNA-binding ligands SL Richardson University of Illinois at Urbana-Champaign, 2012 | | 2012 |
| Modes of nucleic acid binding of small molecule inhibitors for MBNL1xRNA complexation in myotonic dystrophy Type 1 (DM1) CH Wong, SL Richardson, YJ Ho, T Tuccinardi, AM Baranger, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 242, 2011 | | 2011 |
| Synthesis of Novel Trans-substituted Tetra-aryl Porphyrins as Possible Tumor Targeting Agents for Boron Neutron Capture Therapy SL Richardson Murray State University, 2005 | | 2005 |
Gang ZhangCalifornia Institute of TechnologyVerified email at caltech.edu
